Evidence map›Paper›PMID 30988999›Full record

ArticleJournal of pharmacopuncture2019

Renoprotective Effect of

Zohreh Naji Ebrahimi Yazd, Zahra Samadi Noshahr, Sara Hosseinian, Mohammad Naser Shafei, Alireza Ebrahimzadeh Bideskan, Reza Mohebbati, Nazanin Entezari Heravi, Samira Shahraki, Somayeh Mahzari, Abolfazl Khajavi Rad

Open access · diamondAbstract read
In one paragraph

Article in Journal of pharmacopuncture, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Plants (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zohreh Naji Ebrahimi YazdDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra Samadi NoshahrDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Sara HosseinianDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Naser ShafeiDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Alireza Ebrahimzadeh BideskanDepartment of Anatomy and Cell Biology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza MohebbatiDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Nazanin Entezari HeraviDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Samira ShahrakiDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Somayeh MahzariDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abolfazl Khajavi RadDepartment of Physiology, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAdriamycin (ADR) is an important anti-cancer drug which can cause renal toxicity. Given the known anti-inflammatory and antioxidant effects of

methodsFifty male Wistar albino rats were randomly divided into 5 groups including: control, ADR (5 mg/kg), ADR +

resultsAdministration of ADR significantly decreased serum albumin level and increased serum cholesterol and urine protein excretion rate as well as, apoptotic cell numbers compared to the control group (

conclusionOur results showed that the

Indexed as

adriamycinapoptosisextractnephrotic syndromePlantago majorrat

Identifiers

PMID30988999
PMCPMC6461299
OpenAlexW2933579205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.